Literature DB >> 19556760

Advances and advantages in recent central dialysis fluid delivery system.

Yutaka Koda1, Michio Mineshima.   

Abstract

The central dialysis fluid delivery system (CDDS) has been working exclusively in Japan since 1970, a fact which proves that CDDS is useful in the multi-patient treatment with in-center regular hemodialysis. It is a cost-effective, labor-saving and time-tested system with 40 years of experience. Microbial safety is improved by a refined system design, multiple endotoxin retentive filters (ETRF) and daily overnight disinfection of the entire system. Consequently, the usage of backfiltered dialysate is now accepted by regulatory authorities in some bedside consoles and even more the creation of dialysate is possible for infusion to meet its requirements. In many countries, especially in Asia, the number of end-stage renal disease patients is rapidly increasing. CDDS will contribute to such emerging situations with its easy handling and economical advantages. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19556760     DOI: 10.1159/000213494

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  2 in total

1.  Effectiveness of combination of heat water disinfection, continuous water circulation, and minimalized dead space for dialysis piping in maintaining ultrapure dialysis fluid and preventing biofilm formation in a central dialysis fluid delivery system.

Authors:  Fumiyo Ohno; Shinichi Makinose; Yoshihiro Tange
Journal:  J Artif Organs       Date:  2022-09-08       Impact factor: 1.385

2.  Green nephrology and eco-dialysis: a position statement by the Italian Society of Nephrology.

Authors:  Giorgina Barbara Piccoli; Adamasco Cupisti; Filippo Aucella; Giuseppe Regolisti; Carlo Lomonte; Martina Ferraresi; D'Alessandro Claudia; Carlo Ferraresi; Roberto Russo; Vincenzo La Milia; Bianca Covella; Luigi Rossi; Antoine Chatrenet; Gianfranca Cabiddu; Giuliano Brunori
Journal:  J Nephrol       Date:  2020-04-15       Impact factor: 3.902

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.